Anupam Rasayan shares in focus after it secures a six-year chemical supply contract from US firm

Shares of Anupam Rasayan India Ltd. are in focus on Monday, September 7, after the company over the weekend reported that it secured a chemical supply contract with a global industrial major, which has paved the way for a long-term six-year partnership.

Without naming the company, Anupam Rasayan said it was awarded the order by a major specialty metal manufacturer headquartered in the US.

It said the supplies are expected to be made over a multi-year period, with dispatches anticipated to commence from the latter half of the third quarter of the financial year 2027.

While financial considerations of this transaction have not been disclosed, the company said that the consideration value is linked to quantities and deliveries undertaken over the course of the arrangement.

“With the supplies under this contract spread over six-year period, both companies see this as the beginning of a long-term relationship. We are confident that our manufacturing expertise, quality standards and reliability will help us build lasting trust with our partner and we look forward to a strong and enduring partnership in the years ahead,” Anand Desai, the managing director of Anupam Rasayan, said.

On another note, last month, the company raised its consolidated revenue growth guidance to over 30% in the current fiscal from its previous 20-25%.

Anupam Rasayan’s deputy CFO Vishal Thakkar told CNBC-TV18 the growth is largely volume-driven, with the pharma and polymer business continuing to support the performance.

The company reported a mixed set of earnings in the June quarter, with its revenue and profit posting strong annual growth, while EBITDA margins moderating slightly.Its net profit increased 14% to ₹38.6 crore from ₹34 crore in the first quarter last year. Its revenue increased 35% to ₹655 crore from ₹485.8 crore in the previous fiscal.

The company’s earnings before interest taxes depreicaiton and amortization (EBITFA) increased 31% to ₹162.4 crore from ₹124.3 crore while its EBITDA margin contracted to 24;.8% from 25.6% in the year-ago period.

Shares of Anupam Rasayan India ended the previous session 0.5% lower at ₹1,234 apiece. The stock has gained 1.6% in the past month but is down 7% this year, so far.

Also Read: All you need to know about the 12 IPOs worth over ₹7,100 crore that open this week